Browsing by Author Dore, Gregory J.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 29  next >
Issue DateTitleAuthor(s)Citation
2013Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS StudyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory J.; Dunlop, Adrian J; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineAssessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study, Clinical Infectious Diseases, vol.57, Suppl 2, 2013,pp S62-S69
2009Characteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis CHaber, Paul; McCaughan, Geoffrey William; Baker, D; Dore, Gregory J.; Hellard, Margaret; Kaldor, J; Lloyd, Andrew; Marks, P; Matthews, G; Rawlinson, William; Sasadeusz, J; White, Peter A; Yeung, B; Central Clinical School: Addiction Medicine; Central Clinical School: Centenary InstituteCharacteristics and treatment outcomes among HIV-infected individuals in the Australian trial in acute hepatitis C, Clinical Infectious Diseases, vol.48, 5, 2009,pp 650-658
2011Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapyWeltman, Martin; Barton, David; Dore, Gregory J.; Kronborg, Ian J.; Sasadeusz, J; Yoshihara, Motoko; Nepean Clinical School: MedicineClinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy, Addiction, vol.106, 5, 2011,pp 977-984
2007Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatmentKoorey, David; Brew, B.J. (Bruce); Dore, Gregory J.; Kaldore, John; Krahn, M; Maruff, Paul; Thein, Hla Hla; Central Clinical School: MedicineCognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment, HIV Medicine, vol.8,(3),2007,pp 192-202
2016Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypesBooth, David; Douglas, Mark; Eslam, Mohammed; George, Jacob; Leung, Reynold; Liddle, Christopher; Najim, Mustafa; Rahme, Antony; van der Poorten, David; Weltman, Martin; White, Rose; Abate, Maria; Adams, Leon Anton; Berg, Thomas; Bugianesi, Elisabetta; Chan, Henry Lik Yuen; Dore, Gregory J.; et al, Various; Irving, William; Mangia, Alessandra; Miele, Luca; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Childrens Hospital Westmead: Medicine; Nepean Clinical School: Medicine; Central Clinical School: OfficeDiverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes, Hepatology, vol.64, 1, 2016,pp 34-46
2015Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS studyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Dore, Gregory J.; Dunlop, Adrian; Fortier, Emmanuel; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineEffect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study, Journal of Viral Hepatitis, vol.22, 11, 2015,pp 914-925
2008Experience of hepatitis C testing among injecting drug users in Sydney, AustraliaDay, Carolyn; Bates, A; Doab, A; Dore, Gregory J.; Holden, J; Maher, L; Thein, H; White, B; Central Clinical School: Addiction MedicineExperience of hepatitis C testing among injecting drug users in Sydney, Australia, AIDS Care - Psychological and Socio-Medical Aspects of AIDS/Hiv, vol.20,(1),2008,pp 116-123
2002Factors associated with severity of Hepatic Fibrosis in People With Chronic Hepatitis C InfectionDanta, Mark; Farrell, Geoffrey; Ngu, Meng; Batey, Robert G; Desmond, Paul V; Dore, Gregory J.; Harley, Hugh; Hennessy, Lisa; Kaldor, John M.; Li, Yueming; Reed, William; Sievert, William; Vickers, Chris R; Medicine; Western Clinical School: Westmead Millennium Institute; Concord Clinical School: MedicineFactors associated with severity of Hepatic Fibrosis in People With Chronic Hepatitis C Infection, Medical Journal of Australia, vol.177,(N/A),2002,pp 240-245
2010Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC StudyHaber, Paul; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Marks, P; Matthews, G; Petoumenos, Kathy; Central Clinical School: Addiction MedicineFactors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study, Drug and Alcohol Dependence, vol.107, 40239,pp 244-249
2011IL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study.Ahlenstiel, Golo; Booth, David; George, Jacob; O'Connor, Kate; Stewart, Graeme; Suppiah, Vijayaprakash; Weltman, Martin; Abate, Maria; Armstrong, Nicola; Bassendine, Maragaret; Berg, Thomas; Dore, Gregory J.; et al, various; Gaudieri, Silvana; Hellard, Margaret; Irving, William; Powell, Elizabeth E.; Spengler, Ulrich; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineIL28B, HLA-C, and KIR Variants Additively Predict Response to Therapy in Chronic Hepatitis C Virus Infection in a European Cohort: A Cross-Sectional Study., PLoS Medicine, vol.8, 9, 2011,pp e1001092-1-e1001092-8
2009Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.McCaughan, Geoffrey; Weltman, Martin; Cheng, Wendy; Crawford, Darrell; DePamphilis, Jean; Desmond, Paul V; Dore, Gregory J.; Marks, Phillipa; Rawlinson, William D.; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Yoshihara, Motoko; Central Clinical School: Centenary Institute; Nepean Clinical School: MedicineImpact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial., Hepatology, vol.50, 4,pp 1045-1055
2010Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohortHaber, Paul; Dolan, Kate; Dore, Gregory J.; Ffrench, Rosemary; Hosseiny, Parastu; Kaldor, John M; Levy, Michael; Lloyd, Andrew R.; Luciani, Fabio; McCredie, Luke; Rawlinson, William D.; Scheuer, Nicolas; Teutsch, Suzy; Central Clinical School: Addiction MedicineIncidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort, BMC Public Health, vol.10, 633,pp 1-9
2014Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infectionGeorge, Jacob; Leung, Reynold; Button, Peter; Cheng, Wendy; Crawford, Darrell H G; Dore, Gregory J.; Kitson, Matthew; McCaughan, Geoffrey W.; Roberts, Stuart; Sievert, William; Weltman, Martin; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead)Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection, Journal of Gastroenterology and Hepatology, vol.29, N/A, 2014,pp 1458-1462
2010Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosingWeltman, Martin; Cheng, Wendy; Crawford, Darrell; Dore, Gregory J.; Marks, Phillipa; McCaughan, Geoffrey W.; Rawlinson, William; Rizkalla, Bishoy; Roberts, Stuart; Sievert, William; Thommes, James; Yoshihara, Motoko; Nepean Clinical School: MedicineLow virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing, Journal of Hepatology, vol.53, 4,pp 616-623
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2016Maximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infectionDouglas, Mark; George, Jacob; Sheridan, David; Applegate, Tanya; Askew, Ben; Dore, Gregory J.; et al, .; Fenwick, Fiona; Hajarizadeh, Behzad; Matthews, Gail; Neely, Dermot; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical ResMaximum levels of hepatitis C virus lipoviral particles are associated with early and persistent infection, Liver International, vol.36, 12, 2016,pp 1774-1782
2007Modelling the hepatitis C virus epidemic in AustraliaGeorge, Jacob; Weltman, Martin; Bell, Jane; Cooper-Stanbury, Mark; Dolan, Kate; Dore, Gregory J.; et, al; Kaldore, John; Karvelas, Maria; Li, Jiong; Maher, Lisa; Razali, Karina; Thein, Hla Hla; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineModelling the hepatitis C virus epidemic in Australia, Drug and Alcohol Dependence, vol.91,(39509),2007,pp 228-235
2014Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c studyWhite, Bethany; Dore, Gregory J.; Lloyd, Andrew R.; Maher, Lisa; Rawlinson, William; Central Clinical School: Addiction MedicineOpioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study, Medical Journal of Australia, vol.201, 6, 2014,pp 326-329
2010Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus InfectionBooth, David; George, Jacob; Suppiah, Vijayaprakash; Applegate, Tanya; Dore, Gregory J.; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew R.; Marks, Phillipa; Matthews, Gail V; Petoumenos, Kathy; Rawlinson, William; Yeung, Barbara; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium InstitutePotential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection, Hepatology, vol.52, 4, 2010,pp 1216-1224
2011Predictors of deferral of treatment for hepatitis C infection in Australian clinicsGeorge, Jacob; Strasser, Simone; Amin, Janaki; Dore, Gregory J.; Gidding, Heather F.; Jones, Tracey; Law, Matthew G.; Macdonald, Graeme A; Sasadeusz, J; Western Clinical School: Westmead Millennium Institute; Central Clinical School: MedicinePredictors of deferral of treatment for hepatitis C infection in Australian clinics, Medical Journal of Australia, vol.194, 8, 2011,pp 398-402